The selective expansion of functional T cell subsets.

Area of Science:

• Immunology
• Cell Biology
• Biotechnology

Background:

• Adoptive cellular immunotherapy shows promise for treating cancer, infectious diseases, and autoimmune disorders.
• Expansion of specific T cell subsets is crucial for effective cell therapy.

Purpose of the Study:

• To develop a method for selectively expanding diverse T cell subsets for cell therapy.
• To evaluate the efficacy of a novel conditioned medium, XLCM, in T cell expansion.

Main Methods:

• Human peripheral blood low-density mononuclear cells were cultured in FBS-free suspension using XLCM.
• T cell subset expansion and functionality were assessed over 4 weeks.
• Flow cytometry and cytokine analysis were used to characterize expanded T cells.

Main Results:

• XLCM achieved over 100,000-fold expansion of T cells within 4 weeks.
• Sequential expansion of CD4+ and CD8+ T cells observed, with options for selective enrichment.
• Expanded CD4+ T cells produced Th1, Th2, and Th0 cytokines; CD8+ T cells were cytolytically competent.
• Significant expansion of TCRgammadelta+ T cells and persistence of CD4+CD8+ double-positive T cells were noted.

Conclusions:

• XLCM efficiently expands multiple functional T cell subsets, including TCRalphabeta+ and TCRgammadelta+ T cells.
• This method provides a means to obtain selected T cell populations for cellular immunotherapy.
• XLCM represents a promising tool for advancing adoptive cell therapy applications.